Now Enrolling: Phase III Clinical Trial for Generalized Myasthenia Gravis (gMG)
Why this Trial?
Iptacopan is an investigational drug that works by blocking a specific protein in the immune system to help prevent the muscle weakness caused by gMG. This study will evaluate the safety and effectiveness of this treatment compared to a placebo over a 6-month treatment phase, followed by follow-up visits.
The core study lasts roughly 9 months and includes approximately 11 clinic visits at our research site.
Who Can Participate?
You may be eligible to join if you:
- Are between 18 and 85 years of age.
- Have a confirmed diagnosis of Generalized Myasthenia Gravis (gMG) with positive AChR+ antibodies.
- Are currently experiencing significant non-ocular symptoms of gMG (muscle weakness, fatigue, etc.).
- Have been on a stable gMG treatment (like NSISTs, IVIG/PLEX, FcRN antagonists, or Rituximab) for at least 6 months.
Myasthenia Gravis Clinical Trial
Take our 60-second prescreening to see if you qualify to participate in our upcoming study.
Our Contact
We’re here to help! Reach out to us for any inquiries, support, or feedback. Our team is ready to assist you.
- (626) 250-2070
- 960 E. Green St., Suite 310, Pasadena, CA 91106
What to Expect During a Clinical Trial
Screening
Participants undergo a detailed evaluation to confirm eligibility. This may include physical exams, antibody testing, and muscle strength assessments.
Informed Consent
You will receive detailed information about the study, including its purpose, risks, and benefits. Participation is voluntary, and you can withdraw at any time.
Participation
Participants may receive investigational treatments, standard care, or a placebo. Regular medical visits and muscle strength tests will track progress and outcomes.
Follow Ups
After completing the trial, participants are monitored for long-term outcomes and to gather additional data on treatment safety and effectiveness.
How to Get Involved
- Complete the online registration form above.
- Speak with our clinical trial coordinator for more details.
- Schedule a screening appointment to determine your eligibility.
Join Our Myasthenia Gravis Clinical Trials Today
Your participation in MG clinical trials can make a significant difference in advancing treatments and improving care for individuals affected by this rare condition.
Frequently Asked Questions?
What is Myasthenia Gravis?
Myasthenia Gravis is a chronic autoimmune disease that causes muscle weakness by interfering with communication between nerves and muscles.
Who can join a Myasthenia Gravis clinical trial?
Participants often include individuals diagnosed with MG, particularly those who have not responded well to current treatments.
Are clinical trials safe?
Yes, clinical trials follow strict safety protocols and are approved by ethics committees to ensure participant well-being.
Will I be compensated for participating?
Some trials may offer compensation for travel and time, but participation is usually free.
Can I leave the trial if I change my mind?
Yes, participation is voluntary, and you can withdraw at any time.
How long does a clinical trial last?
Trial duration varies but typically ranges from a few weeks to several months, depending on the study design.
01
Have Questions? We’ve Got Answers
Explore our comprehensive FAQ section to find answers to common questions about clinical trials, participation, and more. Get informed and feel confident about taking the next step.
02
Your Safety is Our Priority
Real Voluteer Stories, Real Impact
